TY - JOUR
T1 - Preoperative chemotherapy plus lapatinib or trastuzumab or both in HER2-positive operable breast cancer (CHERLOB trial)
AU - Guarneri, Valentina
AU - Frassoldati, Antonio
AU - Piacentini, Federico
AU - Jovic, Gordana
AU - Giovannelli, Simona
AU - Oliva, Cristina
AU - Conte, PierFranco
PY - 2008
Y1 - 2008
KW - Epidermal growth factor receptor
KW - Immunohistochemistry
KW - Pathologic complete response
UR - http://www.scopus.com/inward/record.url?scp=43249090582&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=43249090582&partnerID=8YFLogxK
U2 - 10.3816/CBC.2008.n.022
DO - 10.3816/CBC.2008.n.022
M3 - Article
C2 - 18621618
AN - SCOPUS:43249090582
VL - 8
SP - 192
EP - 194
JO - Clinical Breast Cancer
JF - Clinical Breast Cancer
SN - 1526-8209
IS - 2
ER -